Validation of potential classification criteria for systemic sclerosis

Medizin & Biologie

• Acro-Osteolysis 8%
• Antibodies 8%
• anticentromere antibody 8%
• Antinuclear Antibodies 5%
• Berlin 5%
• Calcinosis 6%
• Carbon Monoxide 4%
• Cicatrix 4%
• Connective Tissue Diseases 5%
• Contracture 5%
• Databases 2%
• Deglutition Disorders 4%
• Dilatation 4%
• Familial Primary Pulmonary Hypertension 6%
• Fingers 8%
• Friction 5%
• Gastroesophageal Reflux 5%
• Interstitial Lung Diseases 5%
• Kidney 2%
• Mixed Connective Tissue Disease 6%
• Myositis 5%
• Odds Ratio 56%
• Pulmonary Fibrosis 5%
• Raynaud Disease 6%
• Reproducibility of Results 13%
• Rheumatic Diseases 5%
• Rheumatology 5%
• RNA Polymerase III 6%
• Skin 2%
• Systemic Lupus Erythematosus 4%
• Systemic Scleroderma 100%
• Telangiectasis 6%
• Tendons 4%
• Type I DNA Topoisomerase 6%
• Ulcer 4%
• Vital Capacity 5%